Table 2 Patient visit, ultra-wide field imaging, and longitudinal follow-up characteristics
Characteristic | |
|---|---|
Posterior segment indications for initial UWF imaging, n (%) | All eyes n = 19 |
Glaucoma | 14 (73.7) |
History of retinal detachment | 4 (21.1) |
Cystoid macular edema | 2 (10.5) |
Nonexudative AMD | 2 (10.5) |
Exudative AMD | 1 (5.3) |
History of recurrent uveitis | 1 (5.3) |
History of fungal endophthalmitis | 1 (5.3) |
Epiretinal membrane | 1 (5.3) |
Subretinal fibrosis | 1 (5.3) |
Visual acuity, n (%) | Visits with UWF images n = 41 |
Better than 20/100 | 8 (19.5) |
20/100 to 20/400 | 10 (24.4) |
CF | 9 (22.0) |
HM | 11 (26.8) |
LP | 3 (7.3) |
Imaging Obstacles, n (%) | |
BCL | 28 (68.3) |
BCL and RPM | 4 (9.8) |
BCL and PCO | 2 (4.9) |
BCL and silicone oil | 2 (4.9) |
None | 2 (4.9) |
BCL and nystagmus | 1 (2.4) |
BCL and precipitates on posterior KPro | 1 (2.4) |
RPM | 1 (2.4) |
Posterior segment indications for follow-up UWF imaging, n (%) | Eyes with longitudinal follow-up n = 6 |
Glaucoma | 6 (100) |
Nonexudative AMD | 2 (33.3) |
History of retinal detachment | 1 (16.7) |
History of fungal endophthalmitis | 1 (16.7) |
Epiretinal membrane | 1 (16.7) |
Subretinal fibrosis | 1 (16.7) |